The Biosig Project's libbiosig library, specifically versions 3.9.2 and the Master Branch (db9a9a63), contains a heap-based buffer overflow vulnerability identified as CVE-2026-22891. This vulnerability resides in the Intan CLP file parsing component, where improper handling of input data leads to a buffer overflow on the heap. An attacker can exploit this by supplying a specially crafted Intan CLP file, which when parsed, causes memory corruption enabling arbitrary code execution. The flaw does not require any privileges or user interaction, and can be triggered remotely if the application processes untrusted Intan CLP files. The vulnerability is classified under CWE-122, indicating a classic heap-based buffer overflow. The CVSS v3.1 base score is 9.8, reflecting its critical nature with attack vector network (AV:N), low attack complexity (AC:L), no privileges required (PR:N), no user interaction (UI:N), and full impact on confidentiality, integrity, and availability (C:H/I:H/A:H). No patches or fixes are currently linked, and no exploits have been reported in the wild yet. This vulnerability poses a significant risk to any system or application utilizing libbiosig for biomedical signal processing, especially those that ingest Intan CLP files from untrusted sources.

The impact of CVE-2026-22891 is severe for organizations worldwide that rely on libbiosig for processing biomedical signals, particularly those handling Intan CLP files. Successful exploitation allows remote attackers to execute arbitrary code, potentially leading to full system compromise. This can result in unauthorized data access, manipulation or deletion of sensitive biomedical data, disruption of critical healthcare or research operations, and the introduction of persistent malware. Given the criticality and ease of exploitation, attackers could leverage this vulnerability to pivot within networks, steal intellectual property, or sabotage medical research environments. The absence of required privileges or user interaction broadens the attack surface, increasing the likelihood of exploitation in automated or unattended processing scenarios. The vulnerability could also undermine trust in biomedical data integrity and availability, impacting patient care and scientific outcomes.

To mitigate CVE-2026-22891, organizations should first monitor for and apply any official patches or updates released by The Biosig Project as soon as they become available. In the absence of patches, immediate risk reduction can be achieved by restricting or validating all Intan CLP files before processing, ensuring they originate from trusted sources only. Implement input validation and sandboxing techniques to isolate the parsing process, limiting the potential damage of exploitation. Employ runtime protections such as Address Space Layout Randomization (ASLR), Data Execution Prevention (DEP), and heap protection mechanisms to reduce exploitation success. Additionally, consider disabling or removing libbiosig components that handle Intan CLP files if not essential. Network-level controls to block or monitor suspicious file transfers and the use of intrusion detection systems tuned for anomalous behavior in biomedical processing environments can further reduce risk. Finally, maintain robust incident response plans to quickly address any suspected exploitation.